Eleniak Shane Todd Marshall 4

What Happened Shane Eleniak, Chief Product Officer of Calix, reported the acquisition of a 195,000-share derivative (performance-based stock option) on Feb 12, 2026. The transaction is recorded at $0.00 per share because this filing reflects the grant/vesting of a performance-based option rather than a cash purchase. No sale or exercise-for-cash is reported in this transaction.

Key Details

• Transaction date: February 12, 2026; Report filed: February 17, 2026.
• Transaction type/code: A — Grant/Award/Acquisition of a derivative (performance-based option).
• Shares involved: 195,000 options; Reported price: $0.00 (derivative acquisition).
• Shares owned after transaction: Not specified in the provided summary—see the official Form 4 for post-transaction holdings.
• Footnote summary: The option was originally granted Jan 31, 2025. On Feb 12, 2026 the Compensation Committee certified that performance criteria for 100% of the grant were met. Vesting: 25% vested Jan 31, 2026; remaining 75% vest quarterly in equal installments over 36 months beginning Jan 31, 2026, subject to continued employment.
• Filing timeliness: Form 4 lists the filing date (Feb 17, 2026) for the Feb 12 transaction — consult the official filing for any timeliness designation.

Context This filing documents a performance-based option vesting (a derivative award), not a cash exercise or sale. Vesting does not necessarily mean shares were exercised into common stock or sold—those would generate separate filings if they occur. Performance-based vesting is a common form of executive compensation and does not by itself indicate a buy or sell signal.